Loading Events

« All Events

  • This event has passed.

Increasing Equity and Inclusion in Clinical Trials: A Conversation with Sandra Amaro – Hosted by WIB-CT

November 16 @ 4:00 pm - 6:00 pm

Join WIB-Connecticut for an evening with Pfizer colleagues featuring a discussion around clinical trial diversity. We will begin with an hour of networking, followed by an interview with Pfizer’s Head of Clinical Trial Diversity, Center of Excellence, Sandra Amaro. Food and (non-alcoholic) drinks will be served.

Program

4:00 p.m. – 5:00 p.m. Check-in and networking
5:00 p.m. – 5:45 p.m. Interview with Sandra Amaro and audience Q&A
5:45 p.m. – 6:00 p.m. Event closeout

Speaker Bio

Sandra Amaro, MBA, Guest Speaker 
Head of Clinical Trial Diversity Center of Excellence at Pfizer

Sandra Amaro is currently a Senior Director at Pfizer based in Groton, CT, and is the Head of the Clinical Trial Diversity Center of Excellence. In this role, she leads a group of Clinical Trial Diversity Leads and Multicultural Site Development Leads, who are accountable for enabling Pfizer’s Clinical Study Teams to increase equity and inclusion in clinical trials. Within her role, Sandra is also responsible for helping elevate the topic of diversity both within Pfizer and externally. In 2021 Sandra was appointed TransCelerate’s Workstream Lead for their Diversity of Participates in Clinical Trials Workstream.

Sandra has been with Pfizer since May 2004, where she has held different leadership positions within Clinical Development and Operations and Global Clinical Supply. Sandra received her Bachelor of Science in Business and Leadership from Albertus Magnus College and her Master of Business Administration from the University of Rhode Island.

Michelle Johnson, MBA, Interviewer
CEO at Metrum Research Group

Michelle is an experienced leader in management, operations, and marketing, with nearly 20 years of practice covering multiple industries. She is the newly appointed CEO of MetrumRG. In her previous role as COO, she provided strategic business direction to fulfill MetrumRG’s mission and goals and built and led a high-performance business team. With an MBA from Babson College, she has extensive training and practical experience in entrepreneurial business strategy and managing diverse teams.

Details

Date:
November 16
Time:
4:00 pm - 6:00 pm
Website:
https://www.womeninbio.org/event/Conn111622

Join WIB-Connecticut for an evening with Pfizer colleagues featuring a discussion around clinical trial diversity. We will begin with an hour of networking, followed by an interview with Pfizer’s Head of Clinical Trial Diversity, Center of Excellence, Sandra Amaro. Food and (non-alcoholic) drinks will be served.

Program

4:00 p.m. – 5:00 p.m. Check-in and networking
5:00 p.m. – 5:45 p.m. Interview with Sandra Amaro and audience Q&A
5:45 p.m. – 6:00 p.m. Event closeout

Speaker Bio

Sandra Amaro, MBA, Guest Speaker 
Head of Clinical Trial Diversity Center of Excellence at Pfizer

Sandra Amaro is currently a Senior Director at Pfizer based in Groton, CT, and is the Head of the Clinical Trial Diversity Center of Excellence. In this role, she leads a group of Clinical Trial Diversity Leads and Multicultural Site Development Leads, who are accountable for enabling Pfizer’s Clinical Study Teams to increase equity and inclusion in clinical trials. Within her role, Sandra is also responsible for helping elevate the topic of diversity both within Pfizer and externally. In 2021 Sandra was appointed TransCelerate’s Workstream Lead for their Diversity of Participates in Clinical Trials Workstream.

Sandra has been with Pfizer since May 2004, where she has held different leadership positions within Clinical Development and Operations and Global Clinical Supply. Sandra received her Bachelor of Science in Business and Leadership from Albertus Magnus College and her Master of Business Administration from the University of Rhode Island.

Michelle Johnson, MBA, Interviewer
CEO at Metrum Research Group

Michelle is an experienced leader in management, operations, and marketing, with nearly 20 years of practice covering multiple industries. She is the newly appointed CEO of MetrumRG. In her previous role as COO, she provided strategic business direction to fulfill MetrumRG’s mission and goals and built and led a high-performance business team. With an MBA from Babson College, she has extensive training and practical experience in entrepreneurial business strategy and managing diverse teams.